Boston, Massachusetts, United States
I specialize in AI-driven biomedical innovation—designing systems that translate data into biotech applications. First case in Italy to graduate in 5 parallel degrees (MD, Beng, BBiotech, MBiotech, MMedSci). My work has been featured in Science, Cell, and Brain, and I’ve authored two award-winning books, translated and published internationally. I cofounded Oxbridge Clinical, a Boston-based biotech start-up developing a disruptive technology for the detection of microorganisms. I advise across sectors to help organizations harness AI for real-world clinical impact. I founded “A Choice for Life”, a Foundation that has helped 2,000+ students (and counting) with their key life choices.
We are developing new technology that enables point-of-care, germ-specific diagnosis and antibiograms, in a fraction of current cost, time and infrastructure. While doctors can often diagnose infectious diseases clinically, there are no tools to easily identify the microorganism underlying each case: this leads to the overprescription of broad-spectrum antibiotics, contributing to antimicrobial resistance –a global emergency, projected to become the first cause of death by 2050, surpassing cancer. We received Pre-Seed funding and opened a lab, with very promising results, and are now pursuing our Seed.
Author of two award-winning books: Il Metodo Geniale (the brilliant method) and La Facoltà di Scegliere (the faculty to choose). Translated into 4+ languages.
Member of the Scientific Board of the “Tuscany 2050” project, a commission of 15 select experts to design “the Tuscany of the future”, chaired by the President of the Legislative Assembly of Tuscany.
PhD project focused on Artificial Intelligence applied to medicine. (1) Development of an in silico multiomic approach to identify vulnerability factors, molecular targets and drug candidates in disease, with specific focus on neurodegeneration. Supervisor: Prof. Pietro Liò, Computer Laboratory of the University of Cambridge, Bill Gates Building. (2) Characterization of a model of gut-to-brain transportation of α-synuclein using wet-lab techniques. Supervisor: Prof. Maria Grazia Spillantini, FRS, Clifford Allbutt Building. Winner of 5 research scholarships to support the PhD: 1. Vice Chancellor’s Award, Cambridge Trust, University of Cambridge 2. DTP grant of the Medical Research Council, University of Cambridge 3. Darwin College studentship 4. Hevolus Innovation Scholarship, Microsoft partner 5. Ermenegildo Zegna Founder’s Scholarship
Start-up accelerator program of the University of Cambridge.